Assessment of Adherence to Treatment with Ethylmethylhydroxypyridine Malate in Patients with Chronic Cerebral Ischemia Using a Digital Platform

Background. The problem of adherence to medical recommendations is always relevant. Low adherence or nonadherence to treatment has negative clinical and economic effects, such as influence on treatment success, prolongation of disease duration, increased risk of hospitalization, negative outcomes, and increased mortality risk.
The aim of this study was to assess the impact of using the RX Observatory digital platform on adherence to treatment with Etoxydol (ethylmethylhydroxypyridine malate) in patients with chronic cerebral ischemia (CCI).
Materials and methods. Medication adherence was studied in patients with CCI who visited doctors in three Moscow city polyclinics using the RX Observatory digital research platform and digital questionnaires.
Results. The study found that 47% of patients fully adhered to the prescribed medication. Adherence was higher if the medication was prescribed by a medical specialist (general practitioner – 36 %, neurologist – 56 %), although adherence to medical recommendations was higher among patients visiting general practitioners (general practitioner – 48 %, neurologist – 43 %).
Conclusions. The study showed that the RX Observatory platform may be a useful tool for developing medication adherence in patients taking Etoxydol (ethylmethylhydroxypyridine malate).

1. The World health report: 2003: Shaping the future. World Health Organization, URL: https://apps.who.int/iris/handle/10665/42789 (date of the application: 03.05.2023).

2. Healey A., Knapp M., Beecham J., Kemp R., Kirov G., David A. Cost-effectiveness evaluation of compliance therapy for people with psychosis. British journal of psychiatry, 1998, vol. 172, pp. 420-424. doi: 10.1192/bjp.172.5.420.

3. Jin J., Sklar G. E., Oh V. M. S., Li Sh. Ch. Factors affecting therapeutic compliance: A review from the patient’s perspective. Ther clin risk manag, 2008, vol. 4, no. 1, pp. 269-286. doi: 10.2147/tcrm.s1458.

4. Kirchner J. T. Patient compliance in filling new prescriptions (brief article). American family physician, 2000, vol. 62, no. 1, p. 268.

5. McCarthy R. The price you pay for the drug not taken. Business & health, 1998, vol. 16, pp. 27-30.

6. Osterberg L., Blaschke T. Adherence to medication. N engl j med, 2005, vol. 353, pp. 487-497. doi: 10.1056/NEJMra050100.

7. Gusev E. I., Skvortsova V. I., Krylov V. V. Reducing mortality and disability from cerebrovascular diseases in the Russian Federation. Neurological bulletin, 2007, vol. 39, no. 1, pp. 128-133 (in Russian).

8. Kadykov A. S., Manvelov L. S., Shakhparonova N. V. Khronicheskie sosudistye zabolevaniya golovnogo mozga: distsirkulyatornaya entsefalopatiya: rukovodstvo dlya vrachej [Chronic vascular diseases of the brain: dyscirculatory encephalopathy: guide for doctors], 3rd ed., revised and expanded, Moscow, GEOTARMedia Publ., 2014 (in Russian).

9. Tkacheva O. N., Reshetova A. A., Runikhina N. K., Sandakov Ya. P., Lysenkov S. N., Sharashkina N. V., Lesina E. I., Merkusheva L. I. Comparative analysis of the structure of morbidity and geriatric syndromes in low-mobility and bedridden patronage patients. Modern problems of healthcare and medical statistics, 2022, no. 3, pp. 764-785 (in Russian).

10. Zakharov V. V., Sleptsova K. B., Martynova O. O. Chronic ischemia of the brain: a view from the XXI century. Russian medical journal, 2021, vol. 29, no. 5, pp. 45-49 (in Russian).

11. Berezhnaya S. V., Yakupov E. Z. Neuroprotective therapy of chronic cerebral ischemia on an outpatient basis. Journal of Korsakov neurology and psychiatry, 2015, vol. 115, no. 6, pp. 48-52 (in Russian).

12. Tkacheva O. N., Runikhina N. K., Reshetova A. A., Lysenkov S. N., Cherdak M. A., Mkhitaryan E. A., Sandakov Ya. P., Sharashkina N. V. Cognitive status in older people with limited mobility as a predictor of adverse outcomes. Acta biomedica scientifica, 2022, vol. 7, no. 6, pp. 203-211. doi: 10.29413/ABS.2022-7.6.20 (in Russian).

13. Dadasheva M. N., Taranenko N. Yu., Agafonov B. V., Chudakov S. Yu. Pathogenetic therapy with a new domestic antioxidant ethoxidol in cerebrovascular disease. Bulletin of family medicine, 2015, no. 1-2, pp. 12-16 (in Russian).

14. Romanenko A. V., Solovieva E. Yu. Mechanisms of hypoxic-ischemic brain damage in stroke, ways of correction. Nervous diseases, 2021, no. 1, pp. 18-26. doi: 10.24412/2226-0757-2021-12303 (in Russian).

15. Sandakov Ya. P., Runikhina N. K., Reshetova A. A., Efimova A. A., Lysenkov S. N. Patronage of elderly and senile patients: analysis of the current system and definition of a development strategy. Clinical gerontology, 2019, vol. 9-10, no. 25, pp. 32-36 (in Russian).